Pharmacy Pricing Amendments

Summary

The bill adds new definitions for drug‑pricing concepts such as 340B discounts, administrative fees, and spread pricing. It tells pharmacy benefit managers (PBMs) they can only use a "maximum allowable cost" (MAC) for drugs that are on the FDA’s Orange Book or have a comparable rating, are available from a wholesaler in Utah, and are not obsolete. The Insurance Department can now write rules to enforce these changes.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share